T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS. [electronic resource]
Producer: 20171211Description: 1360-1368 p. digitalISSN:- 1555-905X
- Adolescent
- Adult
- Anti-Inflammatory Agents -- therapeutic use
- Area Under Curve
- Biomarkers -- blood
- CD3 Complex -- analysis
- CD4 Antigens -- analysis
- CD40 Ligand -- analysis
- Calcineurin Inhibitors -- therapeutic use
- Child
- Female
- Follow-Up Studies
- Glomerulosclerosis, Focal Segmental -- drug therapy
- Humans
- Immunologic Factors -- therapeutic use
- Interferon-gamma -- analysis
- Interleukin-2 -- analysis
- Lymphocyte Activation
- Male
- Predictive Value of Tests
- Prednisolone -- therapeutic use
- Proteinuria -- drug therapy
- ROC Curve
- Rituximab -- therapeutic use
- T-Lymphocyte Subsets -- chemistry
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.